2009 General Hepatology Update I & II 

|

General Hepatology Update I
Moderators: Gregory J. Gores, MD   Andrea Ewing Reid, MD

The purpose of this forum is to provide the most recent clinical and scientific advances in the practice and study of diseases states associated with the liver. This session is intended for practitioners as well as those who are basic investigators and translational researchers, to learn the most recent clinical advances—grounded in the science of Hepatology. Portal hypertension, non-alcoholic fatty liver disease, and screening for hepatocellular carcinoma are just three of the major topics the membership faces; hence, the designated speakers are leading authorities on these topics to provide timely, state-of-the-art information to the audience.

Goals and Objectives:
• Become more familiar with the latest pathophysiologic mechanisms associated with ascites formation and renal dysfunction as well as potential treatment strategies of both the non-transplant and transplant candidate populations.
• Recognize, in addition to lifestyle modifications, the latest potential medical and surgical therapies for NAFLD as a component of treating metabolic syndrome and obesity.
• Assess, based on current health-outcomes and basic research, which populations should be screened for liver cancer, by which methods, and frequency of screening.

General Hepatology Update II
Moderators: Kenneth D. Rothstein, MD and Ke-Qin Hu, MD

This session will provide up-to-date information on the diagnosis and management of three very important topics related to the care of patients with liver disease.

Goals and Objectives:

• Gain a better understanding of the treatment options of hepatic encephalopathy.
• Become familiar with the clinical presentation of alcoholic hepatitis.
• Recognize the complications of acute liver failure.

Nathan M. Bass, MD, PhD